Feasibility and Acceptability of Collaborative Care for People With Musculoskeletal and Mental Problems
Launched by ROYAL NATIONAL ORTHOPAEDIC HOSPITAL NHS TRUST · Aug 19, 2021
Trial Information
Current as of May 23, 2025
Unknown status
Keywords
ClinConnect Summary
Methodology:
The investigators will perform a single-center, mixed methods two-arm parallel-group Randomized Control trial (RCT), comparing the collaborative care intervention in patients with musculoskeletal (MSK) and co-existing mental conditions with usual care.
The study will be carried out at the Therapies Rehabilitation Outpatient setting, at the Royal National Orthopaedic Hospital NHS Trust, Stanmore, London. The duration of the study will be 12 months and the patient's participation will be for 6 months.
Patients will be approached by their attending physician in their routine ou...
Gender
ALL
Eligibility criteria
- • Participants/ patients
- Inclusion Criteria:
- • Patients over 18 years old, with an MSK condition requiring a therapy outpatient appointment.
- • Scoring ≥ 20 on the PHQ-ADS.
- • Able to provide written informed consent and willing to participate
- • Able and willing to complete questionnaires and study assessments
- Exclusion Criteria:
- • Patients who are already receiving treatment for a psychiatric condition from a specialist mental health service.
- • Scoring \< 20 on the PHQ-ADS.
- • Lacking capacity to consent
- • Unable or unwilling to complete questionnaires and study assessments
- • Participating in other trials
- • Participants/ staff
- • Clinical staff involved in the treatment of the participants allocated to the intervention group
About Royal National Orthopaedic Hospital Nhs Trust
The Royal National Orthopaedic Hospital NHS Trust is a leading specialized healthcare provider dedicated to the diagnosis, treatment, and rehabilitation of musculoskeletal disorders. With a rich history of clinical excellence and a commitment to advancing orthopaedic care, the Trust conducts innovative clinical trials aimed at enhancing patient outcomes and developing cutting-edge therapies. As a key player in research and development, the Trust collaborates with academic institutions and industry partners to drive forward evidence-based practices and improve the quality of life for patients with complex orthopaedic conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanmore, Uk, United Kingdom
Stanmore, London, United Kingdom
Patients applied
Trial Officials
Parashar Ramanuj, MBBS
Principal Investigator
Royal National Orthopaedic Hospital NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials